Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
RAPID SEROLOGICAL TESTS HAVE A ROLE IN ASYMPTOMATIC HEALTH WORKERS COVID-19 SCREENING
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
RAPID SEROLOGICAL TESTS HAVE A ROLE IN ASYMPTOMATIC HEALTH WORKERS COVID-19 SCREENING
Creator
Cafagna, Vito
Chironna, Maria
De Palma, Giuseppe
Garrisi, Vito
Paradiso, Angelo
Silvestris, Nicola
Tufaro, Antonio
D'addabbo, Vincenzo
Larocca, Vittoria
Maria, Angela
Raffaele, Donata
Tommasi, Stefania
Summa, Simonade
source
MedRxiv
abstract
Health workers are at high risk for SARS-CoV-2 infection and, if asymptomatic, for transmitting the virus on to fragile cancer patients. We screened 512 health workers of our Cancer Institute with rapid serological test Viva-Diag analyzing, with colorimetric test,IgG/IgM- COVID-19 associated. Five subjects (1%) resulted with Viva-Diag test not-negative for IgM. All of them had rt-PCR SARS-CoV-2 test negative while for 2 out of 5 cases, CLIA analysis confirmed positive IgM expression. In this original study on health workers we demonstrated that Viva-Diag is able to evidence subjects positive for IgM expression. However, discordant results with respect to rt-PCR and CLIA assays clearly refer to further studies to optimize the utilization of the serological test in asymptomatic and in at risk subjects.
has issue date
2020-04-17
(
xsd:dateTime
)
bibo:doi
10.1101/2020.04.15.20057786
has license
medrxiv
sha1sum (hex)
54af273ed9205cf5aa5e7fb4fc321a14416bc1e2
schema:url
https://doi.org/10.1101/2020.04.15.20057786
resource representing a document's title
RAPID SEROLOGICAL TESTS HAVE A ROLE IN ASYMPTOMATIC HEALTH WORKERS COVID-19 SCREENING
resource representing a document's body
covid:54af273ed9205cf5aa5e7fb4fc321a14416bc1e2#body_text
is
schema:about
of
named entity 'RT-PCR'
named entity 'subject'
named entity 'positive'
named entity 'contact'
named entity 'optimize'
named entity 'utilization'
named entity 'ANALYSIS'
named entity 'ASSOCIATED'
named entity 'SENSITIVITY'
named entity 'CASE'
named entity 'CANCER'
covid:arg/54af273ed9205cf5aa5e7fb4fc321a14416bc1e2
named entity 'assays'
named entity 'evaluation'
named entity 'expression'
named entity 'IgM'
named entity 'subjects'
named entity 'COVID-19'
named entity 'negative'
named entity 'health workers'
named entity 'virus'
named entity 'IgM'
named entity 'serological test'
named entity 'assay'
named entity 'infection'
named entity 'CLIA'
named entity 'Cancer Institute'
named entity 'SARS-CoV-2'
named entity 'ASYMPTOMATIC'
named entity 'asymptomatic'
named entity 'SARS-CoV-2'
named entity 'Bari'
named entity 'IgG'
named entity 'RT-PCR'
named entity 'SARS-CoV-2'
named entity 'transmissible disease'
named entity 'RT-PCR'
named entity 'pneumonia'
named entity 'IgM antibodies'
named entity 'COVID-19 disease'
named entity 'RT-PCR'
named entity 'tested positive'
named entity 'IgM'
named entity 'serum'
named entity 'Shenzhen'
named entity 'plasma'
named entity 'National University of Singapore'
named entity 'venous blood'
named entity 'IgM'
named entity 'SARS-CoV-2'
named entity 'Bari'
named entity 'asymptomatic'
named entity 'preprint'
named entity 'IgG/IgM'
named entity 'antibodies'
named entity 'serological tests'
named entity 'general population'
named entity 'SARS-CoV-2'
named entity 'Nanjing'
named entity 'epidemic'
named entity 'lateral flow'
named entity 'preprint'
named entity 'asymptomatic'
named entity 'long time'
named entity 'recombinant'
named entity 'colorimetric'
named entity 'epidemic'
named entity 'human plasma'
named entity 'follow-up'
named entity 'COVID'
named entity 'SARS-CoV-2'
named entity 'RT-PCR'
named entity 'health workers'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software